Prevalence of metabolic syndrome in Asian Malay urban and rural populations: A comparison of the international diabetes federation (IDF) definition and the national cholesterol education program adult treatment panel III (NCEP ATP III) Asian criteria

被引：0
|
作者：
Ramli, A. S. [1 ]
Ismail, T. S. [1 ]
Ambigga, D. [1 ]
Kaur, M. [1 ]
Koshy, M. [1 ]
Muid, S. [1 ]
Razali, R. [1 ]
Ramli, N. [1 ]
Nawawi, H. [1 ]
Yusoff, K. [1 ]
机构：
[1] Univ Teknol MARA, Fac Med, Shah Alam, Malaysia
来源：
JOURNAL OF HYPERTENSION | 2008年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S353 / S353
页数：1
相关论文
共 50 条
  • [31] Prevalence of Metabolic Syndrome Defined by the International Diabetes Federation and National Cholesterol Education Program Criteria Among Thai Adults
    Aekplakorn, Wichai
    Chongsuvivatwong, Virasakdi
    Tatsanavivat, Pyatat
    Suriyawongpaisal, Paibul
    ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH, 2011, 23 (05) : 792 - 800
  • [32] The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes
    Tong, Peter C.
    Kong, Alice P.
    So, Wing-Yee
    Yang, Xilin
    Ho, Chung-Shun
    Ma, Ronald C.
    Ozaki, Risa
    Chow, Chun-Chung
    Lam, Christopher W.
    Chan, Juliana C. N.
    Cockram, Clive S.
    DIABETES CARE, 2007, 30 (05) : 1206 - 1211
  • [33] Are the patients with metabolic syndrome as defined by International Diabetes Federation criteria more insulin resistant than NCEP-ATP III criteria?
    Kim, J. -H.
    Kwon, H. -S.
    Park, Y. -M.
    Lim, S. -Y.
    Cho, J. -H.
    Kim, S. -R.
    Chang, S. -A.
    Song, K. -H.
    Yoon, K. -H.
    Lee, W. C.
    Cha, B. -Y.
    Lee, K. -W.
    Kang, S. -K.
    Son, H. -Y
    DIABETOLOGIA, 2006, 49 : 236 - 237
  • [34] Intra-abdominal fat is a major determinant of the national cholesterol education program adult treatment panel III criteria for the metabolic syndrome
    Carr, DB
    Utzschneider, KM
    Hull, RL
    Kodama, K
    Retzlaff, BM
    Brunzell, JD
    Shofer, JB
    Fish, BE
    Knopp, RH
    Kahn, SE
    DIABETES, 2004, 53 (08) : 2087 - 2094
  • [35] Comparison of diagnostic criteria and prevalence of metabolic syndrome using WHO, NCEP-ATP III, IDF and harmonized criteria: A case study from urban southeast Nigeria
    Nwankwo, Monday
    Okamkpa, Chikezie Jude
    Danborno, Barnabas
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2022, 16 (12)
  • [36] Development of age-specific adolescent metabolic syndrome criteria that are linked to the adult treatment panel III and international diabetes federation criteria
    Jolliffe, Courtney J.
    Janssen, Ian
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (08) : 891 - 898
  • [37] A comparison of the new international diabetes federation definition of metabolic syndrome to WHO and NCEP definitions in Chinese, European and South Asian origin adults
    Unwin, Nigel
    Bhopal, Raj
    Hayes, Louise
    White, Martin
    Patel, Sheila
    Ragoobirsingh, Dalip
    Alberti, George
    ETHNICITY & DISEASE, 2007, 17 (03) : 522 - 528
  • [38] Serum total cholesterol and LDL cholesterol levels in a select Asian Indian urban population with and without metabolic syndrome by ATP III criteria
    Ramesh, V.
    Singh, A. K.
    Tewari, S.
    Bhatia, E.
    Bhatia, V.
    CLINICAL CHEMISTRY, 2008, 54 (06) : A146 - A146
  • [39] National cholesterol education program expert panel (Adult Treatment Panel III) definition of the metabolic syndrome fails to identify homogeneous subgroups of patients at risk for cardiovascular disease and type 2 diabetes
    St-Pierre, AC
    Bossé, Y
    Pérusse, L
    Bouchard, C
    Tremblay, A
    Després, JP
    Vohl, MC
    Lamarche, B
    CIRCULATION, 2003, 108 (17) : 734 - 734
  • [40] Can we apply the national cholesterol education program adult treatment panel definition of the metabolic syndrome to Asians?
    Tan, CE
    Ma, S
    Wai, D
    Chew, SK
    Tai, ES
    DIABETES CARE, 2004, 27 (05) : 1182 - 1186
12345